TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22789657

Group type: EXPERIMENTAL
Intervention: Online cognitive behavior therapy (CBT) with minimal therapist contact
Number of subjects: 205

Group type: COMPARATOR
Intervention: Clinic delivery of CBT
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Online CBT with brief weekly emails and a single phone call
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Working alliance
Number of subjects: 205
Study: 20421463

Group type: EXPERIMENTAL
Intervention: ALN‐RSV01
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 88
Study: 18947350

Group type: EXPERIMENTAL
Intervention: Comparative judgments (e.g., indicating preference between two stimuli in different domains, comparing wild animals, comparing animals' physical attributes, estimating similarity between objects)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparative judgments
Number of subjects: 0
Study: 15958836

Group type: EXPERIMENTAL
Intervention: Nevirapine (arm A)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Efavirenz (arm B)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Pravastatin (arm C)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Bezafibrate (arm D)
Number of subjects: 130
Study: 11834109

Group type: EXPERIMENTAL
Intervention: JS30 (30% of 1RM, n = 9)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: JS80 (80% of 1RM, n = 10)
Number of subjects: 26

Group type: COMPARATOR
Intervention: C (Control group, n = 7)
Number of subjects: 26
Study: 10520789

Group type: EXPERIMENTAL
Intervention: Stent
Number of subjects: 122

Group type: COMPARATOR
Intervention: DCA
Number of subjects: 122
Study: 7674270

Group type: EXPERIMENTAL
Intervention: First-line combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional strategy
Number of subjects: 0
Study: 2041384

Group type: EXPERIMENTAL
Intervention: Educational intervention consisting of 3 individualized interviews and written informative material.
Number of subjects: 244
Study: 31510408

Group type: EXPERIMENTAL
Intervention: 48-Gbit/s dual polarization Y-00 cipher with 218 phase levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quantum (shot) noise masking
Number of subjects: 0
Study: 29154056

Group type: EXPERIMENTAL
Intervention: Hatha yoga session (video-instructed)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control condition (watching TV)
Number of subjects: 24
Study: 26238568

Group type: EXPERIMENTAL
Intervention: Achillea millefolium (A millefolium) in teabag form for 3 days during 2 menstruation cycles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23611083

Group type: EXPERIMENTAL
Intervention: TMT root treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 62
Study: 21936251

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt (200 g daily containing Lactobacillus acidophilus La5 and Bifidobacterium animalis BB12, 10(7) CFU g(‐1) for each)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional yoghurt (200 g daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional yoghurt
Number of subjects: 70
Study: 20452896

Group type: EXPERIMENTAL
Intervention: Navigated HTO
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional HTO
Number of subjects: 19
Study: 17370032

Group type: EXPERIMENTAL
Intervention: Self-reported cholesterol awareness
Number of subjects: 39876

Group type: EXPERIMENTAL
Intervention: Self-reported cholesterol
Number of subjects: 39876
Study: 16305268

Group type: EXPERIMENTAL
Intervention: Rigid pelvic support belt
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nonrigid pelvic support belt
Number of subjects: 90

Group type: COMPARATOR
Intervention: Exercise and advice
Number of subjects: 90
Study: 12068419

Group type: EXPERIMENTAL
Intervention: HA-coated stems
Number of subjects: 174

Group type: COMPARATOR
Intervention: Non-HA-coated surfaces
Number of subjects: 174
Study: 9428852

Group type: COMPARATOR
Intervention: Atracurium (350 micrograms/kg and 70 micrograms/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cisatracurium (64 micrograms/kg and 10 micrograms/kg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Mivacurium (200 micrograms/kg and 100 micrograms/kg)
Number of subjects: 45
Study: 8559883

Group type: EXPERIMENTAL
Intervention: Videotape designed to increase concern
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Videotape designed to increase information
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control videotape of music
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Unknown means of transmission
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Homosexual activity
Number of subjects: 120
Study: 2227611

Group type: EXPERIMENTAL
Intervention: Combined treatment with phenylpropanolamine (PPA) 50 mg twice daily and estriol 4 mg once daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Estriol 4 mg once daily
Number of subjects: 29
Study: 374177

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Standard treatment (neomycin and cathartics)
Number of subjects: 7
Study: 31578015

Group type: EXPERIMENTAL
Intervention: Nadroparin 1,900 IU (0.2 mL) intravenously (IV group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Nadroparin 3,800 IU (0.4 mL) subcutaneously (SC group)
Number of subjects: 38
Study: 31103547

Group type: EXPERIMENTAL
Intervention: Low-dose endotoxin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 29318860

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (electrodes attachment without electrical stimulation)
Number of subjects: 60
Study: 25315260

Group type: EXPERIMENTAL
Intervention: 5 mg/day ALN
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg/day ALN
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 30
Study: 23193194

Group type: EXPERIMENTAL
Intervention: Balanced article presenting claims both for/against an autism-vaccine link
Number of subjects: 320

Group type: COMPARATOR
Intervention: Link claims only
Number of subjects: 320

Group type: COMPARATOR
Intervention: No-link claims only
Number of subjects: 320

Group type: COMPARATOR
Intervention: Non-health-related information
Number of subjects: 320
Study: 21817116

Group type: EXPERIMENTAL
Intervention: Baicalein (natural product extract)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraperitoneal administration of baicalein by repeated injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (breast cancer cell line with short hairpin RNA against IRF‐1)
Number of subjects: 0
Study: 19657202

Group type: EXPERIMENTAL
Intervention: AFA breathing therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control phase
Number of subjects: 0
Study: 16776706

Group type: EXPERIMENTAL
Intervention: Classic dengue fever
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dengue haemorrhagic fever
Number of subjects: 0
Study: 14976885

Group type: EXPERIMENTAL
Intervention: Integrative Chinese and Western medicine (ICWM) therapeutic program
Number of subjects: 48

Group type: COMPARATOR
Intervention: Western medical therapeutic program
Number of subjects: 48
Study: 10899358

Group type: EXPERIMENTAL
Intervention: Physostigmine infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion of saline
Number of subjects: 10
Study: 9024142

Group type: EXPERIMENTAL
Intervention: Daily drinkers (>= 7 drinks per week)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Reference group (< 1 drink per week)
Number of subjects: 22071
Study: 8329004

Group type: EXPERIMENTAL
Intervention: L-glutamine monofluorophosphate (G-MFP) tablets
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-glutamine monofluorophosphate (G-MFP) powder for oral use
Number of subjects: 12
Study: 3553627

Group type: EXPERIMENTAL
Intervention: Geriatric consultation team (GCT) consultation
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no GCT consultation)
Number of subjects: 185
Study: 29644914

Group type: EXPERIMENTAL
Intervention: Wireless tri-axial accelerometers measuring kinematics during drag flicks
Number of subjects: 0
Study: 27225873

Group type: EXPERIMENTAL
Intervention: docetaxel plus pulse dose AT-101
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: docetaxel plus metronomic dose AT-101
Number of subjects: 32

Group type: COMPARATOR
Intervention: docetaxel
Number of subjects: 32
Study: 25524543

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX) maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 0
Study: 22772570

Group type: EXPERIMENTAL
Intervention: PediGuard
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard probe
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PediGuard and Standard probe
Number of subjects: 18
Study: 21360924

Group type: EXPERIMENTAL
Intervention: Occupational exposure to heavy metals (arsenic, cadmium, lead) in copper smelters
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Smoking smelters
Number of subjects: 166

Group type: COMPARATOR
Intervention: Smoking persons from control group
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Occupational exposure to heavy metals
Number of subjects: 166

Group type: COMPARATOR
Intervention: Tobacco smoke
Number of subjects: 166
Study: 18535882

Group type: EXPERIMENTAL
Intervention: Rest gated SPECT with (99m)Tc-tetrofosmin
Number of subjects: 54
Study: 16281491

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg + aspirin 325 mg (group 1)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Simvastatin 40 mg + aspirin 325 mg (group 2)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg
Number of subjects: 211
Study: 11904653

Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control (no PAC)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: PAC management decisions
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: PAC
Number of subjects: 201
Study: 10464060

Group type: EXPERIMENTAL
Intervention: L-NMMA (13.5 mg/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NO inhalation (30 p.p.m)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline infusion (placebo)
Number of subjects: 14
Study: 8751032

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg q.i.d. for 6 days)
Number of subjects: 8
Study: 2210987

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 631030

Group type: EXPERIMENTAL
Intervention: Hydergine (4.5 mg daily)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31899340

Group type: EXPERIMENTAL
Intervention: Cycling exercise training (50%-70% of heart rate reserve, 30-45 min, 3 sessions/week for 12 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Cycling exercise training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 31
Study: 29779161

Group type: EXPERIMENTAL
Intervention: Masivukeni mHealth application for standardized ART counselling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Department of Health (DoH) support for Masivukeni
Number of subjects: 0
Study: 26683599

Group type: EXPERIMENTAL
Intervention: Intrathoracic impedance monitoring (IIM) alarm turned on and diuretic dose increased by 50% for 1 week in the event of alarm sounding
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (IIM alarm turned off)
Number of subjects: 80
Study: 23985625

Group type: EXPERIMENTAL
Intervention: Peramivir 300 mg twice daily
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Peramivir 600 mg once daily
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 234
Study: 22440067

Group type: EXPERIMENTAL
Intervention: Repetitive thinking about negatively valenced future events
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Repetitive thinking about positively valenced future events
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Repetitive thinking about neutrally valenced future events
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Repetitive thinking (general)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Negative repetitive future thinking
Number of subjects: 108
Study: 20613645

Group type: EXPERIMENTAL
Intervention: Combined training program (CTP) including 5 sets of 8-5 repetition maximum (RM) half squat with 1 30-m sprint after each set.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (CON) performing only technical preparation.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined training program (CTP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 26
Study: 18410584

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin (n = 24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo medication (n = 21)
Number of subjects: 45
Study: 15838561

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12000008

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Ptx) 500 mg l(‐1) added to prime solution
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group received only prime solution
Number of subjects: 25
Study: 10811508

Group type: EXPERIMENTAL
Intervention: docetaxel + gemcitabine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: docetaxel + vinorelbine
Number of subjects: 34
Study: 8670316

Group type: EXPERIMENTAL
Intervention: rHuIL‐1Ra 20 mg administered once, 3 times, or 7 times per week
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: rHuIL‐1Ra 70 mg administered once, 3 times, or 7 times per week
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: rHuIL‐1Ra 200 mg administered once, 3 times, or 7 times per week
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo administered on days rHuIL‐1Ra was not administered
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: rHuIL‐1Ra (all doses) administered once per week during the maintenance phase
Number of subjects: 175
Study: 1999097

Group type: EXPERIMENTAL
Intervention: Helium-oxygen mixture
Number of subjects: 13

Group type: COMPARATOR
Intervention: Oxygen-supplemented room air
Number of subjects: 13
Study: 6660172

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 50
Study: 30632413

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (0.5 g·kg‐1·day‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Carbohydrate beverage (0.5 g·kg‐1·day‐1)
Number of subjects: 32
Study: 28570730

Group type: EXPERIMENTAL
Intervention: Stereotactic conformal radiotherapy (SCRT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional radiotherapy (ConvRT)
Number of subjects: 200
Study: 25571332

Group type: EXPERIMENTAL
Intervention: Robotic-assisted locomotor training (Lokomat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-spastic medication (tizanidine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 0
Study: 22958957

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 2774

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 2774
Study: 19934090

Group type: EXPERIMENTAL
Intervention: Haemoglobin (Hb) of 9-10 g/dl
Number of subjects: 8209

Group type: EXPERIMENTAL
Intervention: Haemoglobin (Hb) > 13 g/dl
Number of subjects: 8209

Group type: EXPERIMENTAL
Intervention: Haemoglobin concentrations across the years 1999 to 2005
Number of subjects: 8209

Group type: EXPERIMENTAL
Intervention: Age, time on dialysis, and diabetes
Number of subjects: 8209
Study: 18585510

Group type: EXPERIMENTAL
Intervention: Pharmacist-managed anticoagulation services (PMAS) follow-up
Number of subjects: 250

Group type: COMPARATOR
Intervention: Physician follow-up
Number of subjects: 250

Group type: COMPARATOR
Intervention: Both groups (PMAS and physician)
Number of subjects: 250
Study: 15860488

Group type: EXPERIMENTAL
Intervention: Paclitaxel 35 mg/m2/24 h continuously infused over 96 h (days 1-4) every 21 days for up to six courses
Number of subjects: 58
Study: 11931067

Group type: EXPERIMENTAL
Intervention: Day-case treatment
Number of subjects: 31

Group type: COMPARATOR
Intervention: In-patient stay
Number of subjects: 31
Study: 10076743

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (CBT) and medication simultaneously (n = 9)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy (CBT) only (n = 6)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Medication while on a wait-list for CBT (n = 6)
Number of subjects: 29

Group type: COMPARATOR
Intervention: No treatment while on a wait-list for CBT (n = 5)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Subsequent administration of CBT to those groups on the wait-list
Number of subjects: 29
Study: 9395604

Group type: EXPERIMENTAL
Intervention: High-density negative ion treatment (2.7 x 10(6) ions/cm3)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-density negative ion treatment (1 x 10(4) ions/cm3)
Number of subjects: 25
Study: 1954643

Group type: EXPERIMENTAL
Intervention: Slow-K tablets
Number of subjects: 107

Group type: COMPARATOR
Intervention: Micro-K 10 Extencaps
Number of subjects: 107
Study: 6835735

Group type: EXPERIMENTAL
Intervention: Mother‐Child Separately
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mother‐Child Together
Number of subjects: 0

Group type: COMPARATOR
Intervention: Child Alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with highest initial blood pressures
Number of subjects: 0
Study: 30223315

Group type: COMPARATOR
Intervention: Intravenous dexamethasone 8 mg (IV)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intraperitoneal dexamethasone 8 mg (IP)
Number of subjects: 80
Study: 29884319

Group type: EXPERIMENTAL
Intervention: Implementation of a care pathway
Number of subjects: 514

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 514
Study: 26831174

Group type: EXPERIMENTAL
Intervention: Hyperbaric combination of magnesium sulphate and ropivacaine by the spinal route
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hyperbaric ropivacaine by the spinal route
Number of subjects: 20
Study: 25157000

Group type: EXPERIMENTAL
Intervention: ATLAS intervention
Number of subjects: 361
Study: 18670735

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15359543

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (1.0% hydrogen peroxide, 0.243% sodium fluoride, sodium tripolyphosphate in a high-cleaning silica base)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Positive Control Dentifrice (hexametaphosphate-containing whitening dentifrice)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Test Dentifrice
Number of subjects: 56
Study: 10675424

Group type: EXPERIMENTAL
Intervention: Diet-and-exercise group (restrict energy intake by 500 kcal/day and exercise for 45 minutes, 4 days/week)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (maintain usual dietary intake and exercise no more than once/week)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diet-and-exercise group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 9292561

Group type: EXPERIMENTAL
Intervention: Single intravenous dose of 750 mg of vancomycin administered 6 to 12 hours before the procedure
Number of subjects: 206

Group type: COMPARATOR
Intervention: No vancomycin prophylaxis (control group)
Number of subjects: 206
Study: 8501998

Group type: EXPERIMENTAL
Intervention: Behavioral interventions intended to encourage testing
Number of subjects: 1565

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: First-round testing
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: First-round intervention
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: First-round adherence
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: Abnormal FOBT result
Number of subjects: 1565
Study: 2883908

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 30
Study: 30639763

Group type: EXPERIMENTAL
Intervention: Tablet-based screening
Number of subjects: 1818

Group type: COMPARATOR
Intervention: Verbal interview screening
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Overall comfort level
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Preference for screening modality
Number of subjects: 1818
Study: 28276987

Group type: EXPERIMENTAL
Intervention: Continuous cold water immersion (12 min at 12 ± 0.4°C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intermittent cold water immersion (4 x 2 min immersion at 12 ± 0.4 °C + 1 min out of water)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 10
Study: 26484851

Group type: EXPERIMENTAL
Intervention: HCSU calendars
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Annual surveys
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Surveys with incentives (gift card)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Mean return interval for HCSU calendars
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Mean return interval for surveys
Number of subjects: 163
Study: 25388906

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Sulpadoxine/pyrimethamine-amodiaquine combination
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Sulpadoxine/pyrimethamine
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: SNPs in IL22
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: SNPs in IL-4R1
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: SNPs in CD36
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: High fever (>39°C for 48 hours)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Fulani participants
Number of subjects: 760
Study: 22678188

Group type: EXPERIMENTAL
Intervention: Radio ads
Number of subjects: 0